Rottenstein Law Group Encouraged by $285,000 Fosamax Lawsuit Verdict in New York

The Rottenstein Law Group, which accepts clients who wish to file Fosamax injury lawsuits, is encouraged by the Feb. 5 report of a $285,000 verdict against Merck in a New York trial over the drug Fosamax, which has been found to weaken bones and cause jaw death.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
“It’s a good sign for those who might have been unsure if pursuing a Fosamax lawsuit was a good idea. Those people should now be further encouraged to contact a lawyer to determine if they have a case.

(PRWEB) February 05, 2013

The Rottenstein Law Group, which accepts clients who wish to file Fosamax injury lawsuits, is encouraged by the Feb. 5 report of a $285,000 verdict against Merck in a New York trial over the drug Fosamax, which has been found to weaken bones and cause jaw death.

According to Reuters, the jury (In re: Scheinberg v. Merck & Co, Inc., U.S. District Court for the Southern District of New York, case no. 09-4119) found that Merck failed to warn plaintiff Rhoda Scheinberg's doctors of potentially serious Fosamax side effects.* Scheinberg, 69, alleged that she had suffered delayed healing and disease in her jaw after a tooth extraction, both caused by Fosamax. This is the second verdict against Merck in a Fosamax trial. Previously, in a Manhattan court, a jury awarded Shirley Boles $8 million because she experienced “jaw death” while taking Fosamax, according to the story.

“This is a victory for those injured by Fosamax,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “It’s a good sign for those who might have been unsure if pursuing a Fosamax lawsuit was a good idea. Those people should now be further encouraged to contact a lawyer to determine if they have a case.”

There are currently about 4,000 lawsuits pending in federal and state courts, according to Reuters. Scheinberg’s suit, filed in 2008, was one of about 1,000 consolidated into a federal multidistrict litigation (MDL-1789) for those alleging jaw-related injuries as a result of taking Fosamax. There is also an MDL for those 842 cases alleging femur fractures as a result of taking the drug (MDL-2243).

The Rottenstein Law Group maintains a Fosamax Injury Lawsuit Center that will help those who believe they were injured by Fosamax evaluate if they have a case.

*reuters.com/article/2013/02/05/merck-fosamax-idUSL1N0B5BWT20130205?type=companyNews&feedType=RSS

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com
http://www.fosamaxinjurylawsuitcenter.com